| Looking through the retrospectoscope in the era of evidence-based medicine |
| E Shaw |
|
JCO Apr 1 1997: 1289–1290.
[PDF]
|
 |
| Dose-intensity in ovarian carcinoma: hold, enough? |
| JT Thigpen |
|
JCO Apr 1 1997: 1291–1293.
[PDF]
|
|
|
Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation |
| |
C Leighton, B Fisher, G Bauman, S Depiero, L Stitt, D MacDonald, and G Cairncross |
| |
JCO Apr 1 1997: 1294–1301.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results |
| |
M Legros, J Dauplat, J Fleury, H Cure, F Suzanne, J Chassagne, JO Bay, C Sol, M Canis, P Condat, B Choufi, F Tavernier, C Glenat, P Chollet, and R Plagne |
| |
JCO Apr 1 1997: 1302–1308.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients |
| |
PJ Stiff, R Bayer, C Kerger, RK Potkul, D Malhotra, DJ Peace, D Smith, and SG Fisher |
| |
JCO Apr 1 1997: 1309–1317.
[Abstract]
[PDF]
|
|
|
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer |
| |
SM Swain, FS Whaley, MC Gerber, S Weisberg, M York, D Spicer, SE Jones, S Wadler, A Desai, C Vogel, J Speyer, A Mittelman, S Reddy, K Pendergrass, E Velez- Garcia, MS Ewer, JR Bianchine, and RA Gams |
| |
JCO Apr 1 1997: 1318–1332.
[Abstract]
[PDF]
|
|
|
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin- containing therapy |
| |
SM Swain, FS Whaley, MC Gerber, MS Ewer, JR Bianchine, and RA Gams |
| |
JCO Apr 1 1997: 1333–1340.
[Abstract]
[PDF]
|
|
|
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients |
| |
T Saarto, C Blomqvist, M Valimaki, P Makela, S Sarna, and I Elomaa |
| |
JCO Apr 1 1997: 1341–1347.
[Abstract]
[PDF]
|
|
|
Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy |
| |
G Gyenes, G Gagliardi, I Lax, T Fornander, and LE Rutqvist |
| |
JCO Apr 1 1997: 1348–1353.
[Abstract]
[PDF]
|
|
|
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer [published erratum appears in J Clin Oncol 1997 Jul;15(7):2763] |
| |
T Ahlert, W Sauerbrei, G Bastert, S Ruhland, B Bartik, N Simiantonaki, J Schumacher, B Hacker, M Schumacher, and V Schirrmacher |
| |
JCO Apr 1 1997: 1354–1366.
[Abstract]
[PDF]
|
|
|
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer |
| |
RI Lalisang, JA Wils, HW Nortier, JT Burghouts, PS Hupperets, FL Erdkamp, HC Schouten, and GH Blijham |
| |
JCO Apr 1 1997: 1367–1376.
[Abstract]
[PDF]
|
|
|
Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis |
| |
JA Petrek, LC Hudgins, M Ho, DR Bajorunas, and J Hirsch |
| |
JCO Apr 1 1997: 1377–1384.
[Abstract]
[PDF]
|
|
|
Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients. International Breast Cancer Study Group |
| |
|
| |
JCO Apr 1 1997: 1385–1394.
[Abstract]
[PDF]
|
|
|
Dose-intensive vinorelbine with concurrent granulocyte colony- stimulating factor support in paclitaxel-refractory metastatic breast cancer |
| |
RB Livingston, GK Ellis, JR Gralow, MA Williams, R White, C McGuirt, BB Adamkiewicz, and CA Long |
| |
JCO Apr 1 1997: 1395–1400.
[Abstract]
[PDF]
|
|
|
Measuring standards of care for early breast cancer in an insured population |
| |
BE Hillner, MK McDonald, L Penberthy, CE Desch, TJ Smith, P Maddux, WP Glasheen, and SM Retchin |
| |
JCO Apr 1 1997: 1401–1408.
[Abstract]
[PDF]
|
|
|
Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study |
| |
G Frasci, P Comella, G Scoppa, C Guida, A Gravina, F Fiore, R Casaretti, A Daponte, A Parziale, and G Comella |
| |
JCO Apr 1 1997: 1409–1417.
[Abstract]
[PDF]
|
|
|
Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study |
| |
S Frustaci, A Buonadonna, E Galligioni, D Favaro, A De Paoli, G Lo Re, R Sorio, S Tumolo, and S Monfardini |
| |
JCO Apr 1 1997: 1418–1426.
[Abstract]
[PDF]
|
|
|
Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma |
| |
KD Miller, PJ Loehrer, R Gonin, and LH Einhorn |
| |
JCO Apr 1 1997: 1427–1431.
[Abstract]
[PDF]
|
|
|
Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin |
| |
YZ Patt, A Hoque, R Lozano, R Pozdur, J Chase, H Carrasco, V Chuang, ES Delpassand, L Ellis, S Curley, M Roh, and DV Jones, Jr |
| |
JCO Apr 1 1997: 1432–1438.
[Abstract]
[PDF]
|
|
|
Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions |
| |
DO Faigel, GG Ginsberg, JS Bentz, PK Gupta, DB Smith, and ML Kochman |
| |
JCO Apr 1 1997: 1439–1443.
[Abstract]
[PDF]
|
|
|
Sexuality and fertility in long-term survivors of testicular cancer |
| |
Y Arai, M Kawakita, Y Okada, and O Yoshida |
| |
JCO Apr 1 1997: 1444–1448.
[Abstract]
[PDF]
|
|
|
Treatment of brain metastases in patients with testicular cancer |
| |
C Bokemeyer, P Nowak, A Haupt, B Metzner, H Kohne, JT Hartmann, L Kanz, and HJ Schmoll |
| |
JCO Apr 1 1997: 1449–1454.
[Abstract]
[PDF]
|
|
|
Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors |
| |
DJ Debono, DK Heilman, LH Einhorn, and JP Donohue |
| |
JCO Apr 1 1997: 1455–1464.
[Abstract]
[PDF]
|
|
|
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial |
| |
AV D'Amico, R Whittington, SB Malkowicz, D Schultz, JE Tomaszewski, and A Wein |
| |
JCO Apr 1 1997: 1465–1469.
[Abstract]
[PDF]
|
|
|
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer |
| |
NA Dawson, WD Figg, MR Cooper, O Sartor, RC Bergan, AM Senderowicz, SM Steinberg, A Tompkins, B Weinberger, EA Sausville, E Reed, and CE Myers |
| |
JCO Apr 1 1997: 1470–1477.
[Abstract]
[PDF]
|
|
|
Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome |
| |
PA Kupelian, VA Kupelian, JS Witte, R Macklis, and EA Klein |
| |
JCO Apr 1 1997: 1478–1480.
[Abstract]
[PDF]
|
|
|
Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer |
| |
MJ Johansen, T Madden, RC Mehra, JG Wood, G Rondon, V Browne, RA Newman, and RE Champlin |
| |
JCO Apr 1 1997: 1481–1491.
[Abstract]
[PDF]
|
|
|
Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9- aminocamptothecin in adult cancer patients |
| |
CH Takimoto, W Dahut, MT Marino, H Nakashima, MD Liang, N Harold, R Lieberman, SG Arbuck, RA Band, AP Chen, JM Hamilton, LR Cantilena, CJ Allegra, and JL Grem |
| |
JCO Apr 1 1997: 1492–1501.
[Abstract]
[PDF]
|
|
|
Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients |
| |
E Gupta, R Mick, J Ramirez, X Wang, TM Lestingi, EE Vokes, and MJ Ratain |
| |
JCO Apr 1 1997: 1502–1510.
[Abstract]
[PDF]
|
|
|
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer |
| |
DP Kelsen, D Martin, J O'Neil, G Schwartz, L Saltz, MT Sung, R von Borstel, and J Bertino |
| |
JCO Apr 1 1997: 1511–1517.
[Abstract]
[PDF]
|
|
|
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial |
| |
M Tempero, P Leichner, G Dalrymple, K Harrison, S Augustine, J Schlam, J Anderson, J Wisecarver, and D Colcher |
| |
JCO Apr 1 1997: 1518–1528.
[Abstract]
[PDF]
|
|
|
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250 |
| |
MG Steffens, OC Boerman, JC Oosterwijk-Wakka, GO Oosterhof, JA Witjes, EB Koenders, WJ Oyen, WC Buijs, FM Debruyne, FH Corstens, and E Oosterwijk |
| |
JCO Apr 1 1997: 1529–1537.
[Abstract]
[PDF]
|
|
|
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial |
| |
SM Blaney, NL Seibel, M O'Brien, GH Reaman, SL Berg, PC Adamson, DG Poplack, MD Krailo, R Mosher, and FM Balis |
| |
JCO Apr 1 1997: 1538–1543.
[Abstract]
[PDF]
|
|
|
Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience |
| |
JP Krischer, S Epstein, DD Cuthbertson, AM Goorin, ML Epstein, and SE Lipshultz |
| |
JCO Apr 1 1997: 1544–1552.
[Abstract]
[PDF]
|
|
|
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities |
| |
P Picci, T Bohling, G Bacci, S Ferrari, L Sangiorgi, M Mercuri, P Ruggieri, M Manfrini, A Ferraro, R Casadei, MS Benassi, AF Mancini, P Rosito, A Cazzola, E Barbieri, A Tienghi, A Brach del Prever, A Comandone, P Bacchini, and F Bertoni |
| |
JCO Apr 1 1997: 1553–1559.
[Abstract]
[PDF]
|
|
|
Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia |
| |
AC Farrow, GR Buchanan, RJ Zwiener, WP Bowman, and NJ Winick |
| |
JCO Apr 1 1997: 1560–1566.
[Abstract]
[PDF]
|
|
|
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia |
| |
A Osterborg, MJ Dyer, D Bunjes, GA Pangalis, Y Bastion, D Catovsky, and H Mellstedt |
| |
JCO Apr 1 1997: 1567–1574.
[Abstract]
[PDF]
|
|
|
Mobilization and transplantation of Philadelphia-negative peripheral- blood progenitor cells early in chronic myelogenous leukemia |
| |
AM Carella, I Cunningham, E Lerma, A Dejana, F Benvenuto, M Podesta, L Celesti, F Chimirri, M Abote, F Vassallo, O Figari, C Parodi, M Sessarego, M Valbonesi, P Carlier, E Prencipe, AM Gatti, D van den Berg, R Hoffman, and F Frassoni |
| |
JCO Apr 1 1997: 1575–1582.
[Abstract]
[PDF]
|
|
|
Secondary acute myelogenous leukemia following safe exposure to etoposide |
| |
KC Stine, RL Saylors, JR Sawyer, and DL Becton |
| |
JCO Apr 1 1997: 1583–1586.
[Abstract]
[PDF]
|
|
|
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients |
| |
Y Bastion, C Sebban, F Berger, P Felman, G Salles, C Dumontet, PA Bryon, and B Coiffier |
| |
JCO Apr 1 1997: 1587–1594.
[Abstract]
[PDF]
|
|
|
Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry |
| |
E Vandenberghe, R Pearce, G Taghipour, L Fouillard, and AH Goldstone |
| |
JCO Apr 1 1997: 1595–1600.
[Abstract]
[PDF]
|
|
|
Allogeneic-blood stem-cell collection following mobilization with low- dose granulocyte colony-stimulating factor |
| |
MR Bishop, SR Tarantolo, JD Jackson, JR Anderson, K Schmit-Pokorny, D Zacharias, ZS Pavletic, SJ Pirruccello, JM Vose, PJ Bierman, PI Warkentin, JO Armitage, and A Kessinger |
| |
JCO Apr 1 1997: 1601–1607.
[Abstract]
[PDF]
|
|
|
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies |
| |
ZS Pavletic, MR Bishop, SR Tarantolo, S Martin-Algarra, PJ Bierman, JM Vose, EC Reed, TG Gross, J Kollath, K Nasrati, JD Jackson, JO Armitage, and A Kessinger |
| |
JCO Apr 1 1997: 1608–1616.
[Abstract]
[PDF]
|
|
|
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial |
| |
JM Vose, AN Pandite, RA Beveridge, RB Geller, MW Schuster, JE Anderson, CF LeMaistre, T Ahmed, A Granena, A Keating, JM Fernandez Ranada, PJ Stiff, I Tabbara, W Longo, EA Copelan, C Nichols, A Smith, DL Topolsky, PJ Bierman, ME Lebsack, M Lange, and L Garrison |
| |
JCO Apr 1 1997: 1617–1623.
[Abstract]
[PDF]
|
|
|
Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients |
| |
C Thieblemont, Y Bastion, F Berger, C Rieux, G Salles, C Dumontet, P Felman, and B Coiffier |
| |
JCO Apr 1 1997: 1624–1630.
[Abstract]
[PDF]
|
|
|
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy |
| |
M Janicek, W Kaplan, D Neuberg, GP Canellos, LN Shulman, and MA Shipp |
| |
JCO Apr 1 1997: 1631–1637.
[Abstract]
[PDF]
|
|
|
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group [published erratum appears in J Clin Oncol 1997 Jul;15(7):2762] |
| |
JM Connors, P Klimo, G Adams, BF Burns, I Cooper, RM Meyer, SE O'Reilly, J Pater, I Quirt, A Sadura, C Shustik, J Skillings, S Sutcliffe, S Verma, S Yoshida, and B Zee |
| |
JCO Apr 1 1997: 1638–1645.
[Abstract]
[PDF]
|
|
|
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients |
| |
M Lazzarino, E Orlandi, M Paulli, J Strater, C Klersy, U Gianelli, L Gargantini, MT Rousset, M Gambacorta, E Marra, T Lavabre-Bertrand, U Magrini, C Manegold, C Bernasconi, and P Moller |
| |
JCO Apr 1 1997: 1646–1653.
[Abstract]
[PDF]
|
|
|
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte |
| |
D Wendum, C Sebban, P Gaulard, B Coiffier, H Tilly, D Cazals, A Boehn, RO Casasnovas, R Bouabdallah, J Jaubert, A Ferrant, J Diebold, A de Mascarel, and C Gisselbrecht |
| |
JCO Apr 1 1997: 1654–1663.
[Abstract]
[PDF]
|
|
|
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants |
| |
A Majlis, WC Pugh, MA Rodriguez, WF Benedict, and F Cabanillas |
| |
JCO Apr 1 1997: 1664–1671.
[Abstract]
[PDF]
|
|
|
Patient preferences for interferon alfa in multiple myeloma |
| |
H Ludwig, E Fritz, J Neuda, and BG Durie |
| |
JCO Apr 1 1997: 1672–1679.
[Abstract]
[PDF]
|
|
|
Socioeconomic status and cancer survival in Ontario |
| |
WJ Mackillop, J Zhang-Salomons, PA Groome, L Paszat, and E Holowaty |
| |
JCO Apr 1 1997: 1680–1689.
[Abstract]
[PDF]
|
|
|
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer |
| |
J Herrstedt, T Sigsgaard, J Handberg, BM Schousboe, M Hansen, and P Dombernowsky |
| |
JCO Apr 1 1997: 1690–1696.
[Abstract]
[PDF]
|
|
|
Methodologic issues in effectiveness research on palliative cancer care: a systematic review |
| |
GC Rinck, GA van den Bos, J Kleijnen, HJ de Haes, E Schade, and CH Veenhof |
| |
JCO Apr 1 1997: 1697–1707.
[Abstract]
[PDF]
|
|
| Angiosarcoma |
| RH Vonderheide, MD Fleming, G Carter, S Singer, and G Demetri |
|
JCO Apr 1 1997: 1708–1709.
[PDF]
|
|
| Treatment of acute myelogenous leukemia |
| S Slater, AZ Rohatiner, M Murphy, J Amess, M Carter, TA Lister, S Johnson, and M Ewings |
|
JCO Apr 1 1997: 1710–1711.
[PDF]
|
|
| BCRA 1 testing guidelines for high-risk patients |
| S Sorscher and P Levonian |
|
JCO Apr 1 1997: 1711.
[PDF]
|
|
